KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Amortizatization of Intangibles: 2017-2019

Historic Amortizatization of Intangibles for Aquestive Therapeutics (AQST) over the last 2 years, with Sep 2019 value amounting to $13,000.

  • Aquestive Therapeutics' Amortizatization of Intangibles changed negligibly% to $13,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $88,000, marking a year-over-year decrease of 3.30%. This contributed to the annual value of $130,000 for FY2018, which is 6.56% up from last year.
  • Per Aquestive Therapeutics' latest filing, its Amortizatization of Intangibles stood at $13,000 for Q3 2019, which was down 0.00% from $13,000 recorded in Q2 2019.
  • Over the past 5 years, Aquestive Therapeutics' Amortizatization of Intangibles peaked at $34,000 during Q1 2018, and registered a low of $12,000 during Q2 2018.
  • Over the past 3 years, Aquestive Therapeutics' median Amortizatization of Intangibles value was $28,000 (recorded in 2018), while the average stood at $23,333.
  • Per our database at Business Quant, Aquestive Therapeutics' Amortizatization of Intangibles tumbled by 58.06% in 2018 and then grew by 8.33% in 2019.
  • Aquestive Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $32,000 in 2017, then fell by 12.50% to $28,000 in 2018, then remained steady at $13,000 in 2019.
  • Its Amortizatization of Intangibles was $13,000 in Q3 2019, compared to $13,000 in Q2 2019 and $34,000 in Q1 2019.